Where does Tim Xiao work?

Tim Xiao is Partner at Delos Capital and Board director at Thermalin.

What does Tim Xiao invest in?

Tim Xiao invests in Biotech, Healthtech, Medical Devices.

What companies has Tim Xiao invested in?

Investments tracked here include Curatia Medical, Eccogene, LipoSeuticals, Reniva, STRM.Bio, Zenas.

Where did Tim Xiao go to school?

Tim Xiao studied at The Johns Hopkins University (Master of Science - MS, Biotechnology); Shanghai Jiao Tong University (B.Sc., International Economics & Trade); The University of British Columbia (Exchange, International Business).

Does Tim Xiao lead rounds?

Yes — Tim Xiao has led 6 tracked investments.

Tim Xiao

Investor

Partner at Delos Capital · Board director at Thermalin

Hong Kong

About

Partner and founding member of Delos Capital with 16 years in life science advisory and investing; leads investments and sits on or observes boards of numerous biotech and medtech companies. Previously spent seven years in investment banking, most recently at Goldman Sachs.

Contact· self-published, not guessed

t•••@deloscapital.comreveal

Invests in

BiotechHealthtechMedical Devices

Board director at Thermalin

Intro paths

→

In turn, Tim can intro founders to Thermalin's investors below.

Thermalin's investors · 1

Delos CapitalCambridge · since 2019

Experience

EccogeneChief Financial Officercurrent2025 — presentCambridge, Massachusetts, United States
EccogeneBoard Member2020 — 2025Cambridge, Massachusetts, United States
Delos CapitalPartnercurrent2022 — presentHong Kong SAR
Delos CapitalPrincipal2017 — 2021Hong Kong SAR
Delos CapitalVice President2014 — 2016Hong Kong SAR
STRM.BIOBoard Membercurrent2021 — presentCambridge, Massachusetts, United States
Sirius TherapeuticsBoard Observercurrent2024 — presentSan Diego, California, United States
Rgenta Therapeutics Inc.Board Observercurrent2022 — presentWoburn, Massachusetts, United States
ReNiva Inc.Board Member2024 — 2025
Curatia MedicalBoard Member2015 — 2025Suzhou, Jiangsu, China
Allecra TherapeuticsBoard Observer2016 — 2025Weil am Rhein, Baden-Württemberg, Germany
Zenas BioPharmaBoard Member2024 — 2025Waltham, Massachusetts, United States
Odeon TherapeuticsChief Executive Officer2022 — 2024Shanghai, China
OncoMyx TherapeuticsBoard Member2019 — 2024Phoenix, Arizona, United States
Intrinsic Therapeutics, IncBoard Observer2017 — 2024Woburn, Massachusetts, United States
Clover BiopharmaceuticalsBoard Member2019 — 2022Chengdu, Sichuan, China
Luqa PharmaceuticalsBoard Member2018 — 2021Shanghai, China
Thermalin Inc.Board Member2018 — 2021Boston, Massachusetts, United States
Goldman SachsSenior Associate, Investment Banking2010 — 2014Beijing
CICCAnalyst, Investment Banking2008 — 2010Beijing, China
A.T. KearneyIntern2007 — 2008

Skills & more

Valuation54Mergers11Investment Banking34Process Management5Investment Advisory12Mergers & Acquisitions33Strategy19Investments9Financial Analysis7Market Analysis13Financial Modeling12Private Equity7

+10 more

FinanceCorporate FinanceDue DiligenceIPOBusiness StrategyCapital MarketsVenture CapitalEquitiesEmerging MarketsInternational Business

Languages Chinese · English

Chartered Financial Analyst — CFA Institute
Financial Risk Manager — Global Association of Risk Professionals (GARP)

From Tim's professional profile.

Deals · 1

RenivaLed round

via Delos Capital

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Led

Curatia MedicalEccogeneLipoSeuticalsSTRM.BioZenas

Board seats

AllecraApama MedicalAtia VisionClover BiopharmaCuratia MedicalEccogeneLipoSeuticalsLuqa PharmaRgentaSiriusSTRM.BioZenas

Per the firm's website.

Colleagues at Delos Capital

Agnes Kwok

Financial Controller at Delos Capital

Andrea Lok

Executive Assistant at Delos Capital

Carrie Greenaway

Office Manager at Delos Capital

Eric Huang

Partner at Delos Capital

Faris Lodin

Managing Director at Sterling Equity

Hank Huang

Associate at Delos Capital

Henry Chen

Managing Partner at Delos Capital

Lee Cooper

Managing Director at Delos Capital

Frequently asked questions

Who is Tim Xiao?: Partner and founding member of Delos Capital with 16 years in life science advisory and investing; leads investments and sits on or observes boards of numerous biotech and medtech companies. Previously spent seven years in investment banking, most recently at Goldman Sachs.
Where does Tim Xiao work?: Tim Xiao is Partner at Delos Capital and Board director at Thermalin.
What does Tim Xiao invest in?: Tim Xiao invests in Biotech, Healthtech, Medical Devices.
What boards does Tim Xiao sit on?: Tim Xiao holds tracked board seats at Allecra, Apama Medical, Atia Vision, Clover Biopharma, Curatia Medical, Eccogene, LipoSeuticals, Luqa Pharma, Reniva, Rgenta.
What companies has Tim Xiao invested in?: Investments tracked here include Curatia Medical, Eccogene, LipoSeuticals, Reniva, STRM.Bio, Zenas.
Where did Tim Xiao go to school?: Tim Xiao studied at The Johns Hopkins University (Master of Science - MS, Biotechnology); Shanghai Jiao Tong University (B.Sc., International Economics & Trade); The University of British Columbia (Exchange, International Business).
Does Tim Xiao lead rounds?: Yes — Tim Xiao has led 6 tracked investments.

Same school

Also attended The Johns Hopkins University357

Dave JohnsonCo-founder & CEO of Dash Bio Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital Partners Demi ObayomiPrincipal at Sapphire Ventures Jun JeonInvestor at Khosla Ventures Nicole FraenkelInvestor at Khosla Ventures

+ 351 more

Also attended Shanghai Jiao Tong University91

Collin WallaceGeneral Partner at Lobby Capital Josh RiezmanChief Legal & Strategy Officer at GSR Meera BissoondeealInvestor at 13books Capital Ali Clunies-RossPartner & Co-Head VC at Artesian Robert ShanManaging Partner Redstone Hong Kong at Redstone Xiao (Sean) YangAssociate at Shunwei Capital

+ 85 more

Also attended The University of British Columbia375

Joan MirallesHead of Administration & Valuation at Inveready Technology Investment Group Zack GrimmerInvestor at IVP (Institutional Venture Partners)Rares CrisanInvestor at Notable Capital Marianne WuVenture Partner at Congruent Ventures Brendan BakerPartner at Rackhouse Venture Management Lp Ali KashaniVenture Partner at Think+ Ventures Management, Llc

+ 369 more

Shared employers

Also worked at Goldman Sachs2,000

Marc AndreessenCo-founder & General Partner at Andreessen Horowitz Josh KushnerFounder & CEO of Thrive Capital Sarah GuoFounder & General Partner of Conviction Fred EhrsamCo-founder and Senior Advisor at Paradigm; founder of Nudge Matt HuangCo-founder and Managing Partner at Paradigm David VélezFounder & CEO of Nubank

+ 1,994 more

Also worked at CICC22

Gaby PanVentures Manager at Qualcomm Ventures Kate WangAssociate at FinTech Collective Jingsong ZhouAssociate at Shunwei Capital Ren DuManaging Director at Heuristic Capital Partners Jessie Jia GuoInvestment Partner at Next Legacy Partners Shawn NiuInvestment Manager at DCM Ventures

+ 16 more

Also worked at A.T. Kearney202

Katrin GeyskensExecutive Director at Capricorn Venture Partners Wendy XiaoPartner at Northzone Sheng Xin YuInvestment Analyst at Burda Principal Investments Adrián MachoAssociate at Inveready Technology Investment Group Patrik BackmanGeneral Partner at OpenOcean Ralf WahlstenChairman at OpenOcean

+ 196 more